References
- Magliano DJ, Islam RM, Barr ELM, et al. Trends in incidence of total or type 2 diabetes: systematic review. BMJ. 2019;366:l5003. doi:10.1136/bmj.l5003
- Kuiper JG, Bakker M, Beest FJA P-V, Herings RMC. Existing data sources for clinical epidemiology: the PHARMO database network. Clin Epidemiol. 2020;12:415–422. doi:10.2147/CLEP.S247575
- Overbeek JA, Swart KMA, Houben E, Beest FJA P-V, Herings RMC. Completeness and representativeness of the PHARMO General Practitioner (GP) data: a comparison with national Statistics. Clin Epidemiol. 2023;15:1501–1511. doi:10.2147/CLEP.S389598
- Geiss LS, Wang J, Cheng YJ, et al. Prevalence and incidence trends for diagnosed diabetes among adults aged 20 to 79 years, United States, 1980–2012. JAMA. 2014;312(12):1218–1226. doi:10.1001/jama.2014.11494
- Statistics Netherlands (CBS). Obesity, smoking and alcohol consumption barely down since 2018; 2022. Available from: https://www.cbs.nl/nl-nl/nieuws/2022/10/overgewicht-roken-en-alcoholgebruik-nauwelijks-gedaald-sinds-2018#:~:text=In%202021%20hadden%20nagenoeg%20evenveel,naar%2021%20procent%20in%202021. Accessed Feb 24, 2023.
- Rijksinstituut voor Volksgezondheid en Milieu (RIVM). Dutch are eating increasingly healthier: more plant-based and less red and processed meat; 2022. Available from: https://www.wateetnederland.nl/conclusies. Accessed Feb 24, 2023.
- Rutten GEHM, De Grauw WJC, Nijpels G, et al. NHG-Standaard Diabetes mellitus type 2 (derde herziening). Huisarts Wet. 2013;56(10):512–525.
- Riet E, Alssema M, Rijkelijkhuizen JM, Kostense PJ, Nijpels G, Dekker JM. Relationship between A1C and glucose levels in the general Dutch population: the new Hoorn study. Diabetes Care. 2010;33(1):61–66. doi:10.2337/dc09-0677
- Mooy JM, Grootenhuis PA, de Vries H, et al. Prevalence and determinants of glucose intolerance in a Dutch caucasian population. the Hoorn study. Diabetes Care. 1995;18(9):1270–1273. doi:10.2337/diacare.18.9.1270